Essential polyunsaturated fatty acid and lipid peroxide levels in never-medicated and medicated schizophrenia patients

This publication has 56 references indexed in Scilit:

• Supplementation with a combination of ω-3 fatty acids and antioxidants (vitamins E and C) improves the outcome of schizophrenia
  Schizophrenia Research, 2003
• Reduced erythrocyte membrane essential fatty acids and increased lipid peroxides in schizophrenia at the never-medicated first-episode of psychosis and after years of treatment with antipsychotics
  Schizophrenia Research, 2002
• Is there an association between the effects of clozapine on the production of reactive oxygen metabolites by blood monocytes and clinical outcome in neuroleptic-resistant schizophrenia?
  Schizophrenia Research, 1998
• Long-term morbidity associated with delayed treatment of first admission schizophrenic patients: a re-analysis of the Camarillo State Hospital data
  Psychological Medicine, 1997
• Genetic variant near cytosolic phospholipase A2 associated with schizophrenia
  Schizophrenia Research, 1996
• Red blood cell membrane dynamics in schizophrenia. II. Fatty acid composition
  Schizophrenia Research, 1994
• Membrane phospholipid metabolism and schizophrenia: an in vivo 31P-MR spectroscopy study
  Schizophrenia Research, 1994
• Frontal lobe metabolism and cerebral morphology in schizophrenia: 31P MRS and MRI studies
  Schizophrenia Research, 1993
• Schizophrenia: manifestations, incidence and course in different cultures A World Health Organization Ten-Country Study
  Psychological Medicine. Monograph Supplement, 1992
• The effect of ischemia and recirculation, hypoxia and recovery on anti-oxidant factors and β-adrenoceptor density
  Biochemical and Biophysical Research Communications, 1987